Collaboration/cooperation with external institutions GloPID-R (Global Research Collaboration for Infectious Disease Preparedness)

The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international cooperation initiative established in 2013 with the reflection of the global response to the sudden Ebola epidemic in 2014, the European Commission discussed with the Heads of International Biomedical Research Organizations (HIROs) and created this initiative. GloPID-R facilitates information exchange between countries during ordinary times and promotes the member organizations to discuss countermeasures and preparedness in order to ensure an effective response within 48 hours of an infectious disease outbreak that is a potential pandemic threat

The participating members include the governmental and non-governmental funding agencies of the following countries: Argentina, Italy, India, UK, Egypt, Canada, Kenya, Mexico, the European Commission, Germany, France, Brazil, Spain, Australia, Korea, Norway, South Africa, Thailand, US and whole Africa (African Academy of Sciences). The Bill & Melinda Gates Foundation and the Welcome Trust are among the private funders that became the members of GloPID-R. AMED of Japan joined the GloPID-R in August 2015.

Data sharing, control measures against Zika virus infection, and Readiness Plan are among the main topics being discussed at GloPID-R. On February 10, 2016, the AMED cosigned the `Statement on Data Sharing in Public Health Emergencies', along with academic publishers (such as Science Journal and The Lancet) and the overseas funding organizations(such as in UK, Canada, USA, People's Republic of China, India, Germany, France, South Africa, the Netherlands, India). The Welcome Trust Foundation, a GloPID-R member, initially mobilized this movement. .

AMED is committed to GloPID-R activities in such ways as; participation in the Annual General Assemblies, information sharing about AMED funding for the research projects on Middle East Respiratory Syndrome (MERS) and Zika virus, and participation in discussions and exchange of views at GloPID-R. In late November 2016, AMED-funded researchers participated in the `GloPID-R Zika Virus Research Workshop' held in Brazil. Global collaboration is essential to promote infectious diseases research. .AMED is going to keep up a good relationship with GloPID-R members and contribute to the research and development on a global scale.